Immune responses in the Parkinson's disease brain

Immune responses in the Parkinson's disease brain

Immune changes occur in all neurodegenerative conditions, but there are significant differences between diseases. For Parkinson's disease (PD), the immune system involvement is still being identified with considerable promise for therapeutic targeting. Post-mortem analyses of PD patient brains...

Full description

Bibliographic Details
Main Authors:	Fiona Weiss, Adahir Labrador-Garrido, Nicolas Dzamko, Glenda Halliday
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	Neurobiology of Disease
Subjects:	Glia Cytokine Immune Inflammation Alpha-synuclein
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996122000924

Similar Items

Editorial: Updates on inflammation in Parkinson's disease
by: Nicolas Dzamko, et al.
Published: (2023-01-01)

Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations
by: Adahir Labrador-Garrido, et al.
Published: (2023-10-01)

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
by: Alice J. White, et al.
Published: (2018-11-01)

Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?
by: Panagiota Mavroeidi, et al.
Published: (2022-07-01)

Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?
by: Luca Magistrelli, et al.
Published: (2022-03-01)

Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?
by: Elzbieta Janda, et al.
Published: (2018-04-01)

SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models
by: Oh‐Chan Kwon, et al.
Published: (2021-04-01)

Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
by: Shuanglong Yi, et al.
Published: (2022-11-01)

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
by: Atashrazm F, et al.
Published: (2016-10-01)

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson’s Disease: Roads to Biomarker Discovery
by: Anna Picca, et al.
Published: (2021-10-01)

Extracellular alpha-synuclein: Sensors, receptors, and responses
by: Renato Domingues, et al.
Published: (2022-06-01)

Inflammatory Responses to Monomeric and Aggregated α-Synuclein in Peripheral Blood of Parkinson Disease Patients
by: Federica Piancone, et al.
Published: (2021-03-01)

Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
by: Thuy Thi Lai, et al.
Published: (2022-01-01)

Role of exosomes in the pathogenesis of inflammation in Parkinson’s disease
by: Ke-Lu Li, et al.
Published: (2022-01-01)

Thoracic trauma promotes alpha-Synuclein oligomerization in murine Parkinson's disease
by: Wolfgang P. Ruf, et al.
Published: (2022-11-01)

Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery
by: Milo Jarno Basellini, et al.
Published: (2023-02-01)

Passive Immunization in Alpha-Synuclein Preclinical Animal Models
by: Jonas Folke, et al.
Published: (2022-01-01)

Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson’s Disease
by: Dominika Fricova, et al.
Published: (2020-11-01)

Alpha-synuclein as a biomarker of Parkinson’s disease
by: S. N. Pchelina
Published: (2017-02-01)

Immunotherapy in Parkinson’s disease: Current status and future directions
by: Diptaman Chatterjee, et al.
Published: (2019-12-01)

The Role of Glial Mitochondria in α-Synuclein Toxicity
by: Yu-Mi Jeon, et al.
Published: (2020-11-01)

Escalating Bi-Directional Feedback Loops between Proinflammatory Microglia and Mitochondria in Ageing and Post-Diagnosis of Parkinson’s Disease
by: Shane Michael Ravenhill, et al.
Published: (2023-05-01)

Dysfunctional mitochondria uphold calpain activation: Contribution to Parkinson's disease pathology
by: A. Raquel Esteves, et al.
Published: (2010-03-01)

Inflammation, Infectious Triggers, and Parkinson's Disease
by: Elisa Caggiu, et al.
Published: (2019-02-01)

Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson’s Disease Risk
by: Alix Booms, et al.
Published: (2021-10-01)

Modeling the dynamics of innate and adaptive immune response to Parkinson's disease with immunotherapy
by: Salma M. Al-Tuwairqi, et al.
Published: (2023-01-01)

Human Brain Lipidomics: Pilot Analysis of the Basal Ganglia Sphingolipidome in Parkinson’s Disease and Lewy Body Disease
by: Aaron W. Beger, et al.
Published: (2022-02-01)

A Novel Microfluidic Cell Co-Culture Platform for the Study of the Molecular Mechanisms of Parkinson’s Disease and other Synucleinopathies
by: João Tiago Fernandes, et al.
Published: (2016-11-01)

Different inflammation responses modulate Müller glia proliferation in the acute or chronically damaged zebrafish retina
by: Maria Iribarne, et al.
Published: (2022-08-01)

Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson’s Disease
by: Sandra Duperrier, et al.
Published: (2022-08-01)

The role of resveratrol as a natural modulator in glia activation in experimental models of stroke
by: Farzaneh Vafaee, et al.
Published: (2020-10-01)

Lifelong Impacts of Moderate Prenatal Alcohol Exposure on Neuroimmune Function
by: Shahani Noor, et al.
Published: (2018-05-01)

The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
by: Emily M. Klann, et al.
Published: (2022-01-01)

The Mechanism and Function of Glia in Parkinson's Disease
by: Xinguo Zhang, et al.
Published: (2022-05-01)

Alpha-Synuclein Aggregation in Parkinson's Disease
by: E. Srinivasan, et al.
Published: (2021-10-01)

Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson’s Disease Progression in Mice
by: Seon-Young Park, et al.
Published: (2023-10-01)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
by: Maria Angela Samis Zella, et al.
Published: (2019-01-01)

Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
by: Yaping Chu, et al.
Published: (2009-09-01)

Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
by: Hala Shaheen, et al.
Published: (2020-02-01)

Portrait of blood-derived extracellular vesicles in patients with Parkinson’s disease
by: Jérôme Lamontagne-Proulx, et al.
Published: (2019-04-01)